Literature DB >> 14746529

Systemic mastocytosis.

Cem Akin1, Dean D Metcalfe.   

Abstract

Systemic mastocytosis is a clonal disorder of the mast cell and its progenitor. The symptoms of systemic mastocytosis are due to the pathologic accumulation and activation of mast cells in various tissues such as bone marrow, skin, gastrointestinal tract, liver, and spleen. Recent studies revealed striking differences between the molecular and cellular biology of mast cells in patients with mastocytosis and those of healthy individuals. These findings are being used in formulating diagnostic criteria as well as designing novel treatment approaches to the disease.

Entities:  

Mesh：

Year:  2004        PMID： 14746529     DOI： 10.1146/annurev.med.55.091902.103822

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN： 0066-4219            Impact factor:   13.739


  71 in total

1.  Orthopaedic case of the month: Recurrent thigh pain in a 44-year-old man.

Authors:  Adam O Burzynski; Alfredo Luis Valente; Timothy A Damron
Journal:  Clin Orthop Relat Res       Date:  2012-04-24       Impact factor: 4.176

Review 2.  Advanced imaging of skeletal manifestations of systemic mastocytosis.

Authors:  J Fritz; E K Fishman; J A Carrino; M S Horger
Journal:  Skeletal Radiol       Date:  2012-02-26       Impact factor: 2.199

3.  Systemic mastocytosis presenting with acute oliguric renal failure: report of a case and review of the literature.

Authors:  Ann E Moore; William H Johnston; Aviv Hever; Susy Peng; Dean A Kujubu
Journal:  Int Urol Nephrol       Date:  2010-11-27       Impact factor: 2.370

Review 4.  Urticaria pigmentosa and mastocytosis: the role of immunophenotyping in diagnosis and determining response to treatment.

Authors:  Cem Akin; Peter Valent; Luis Escribano
Journal:  Curr Allergy Asthma Rep       Date:  2006-07       Impact factor: 4.806

5.  Mastocytosis: the great masquerader.

Authors:  James S W Kong; Suzanne Teuber; Rosemary Hallett; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2006-02       Impact factor: 8.667

6.  Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis.

Authors:  Cem Akin; Linda M Scott; Can N Kocabas; Nataliya Kushnir-Sukhov; Erica Brittain; Pierre Noel; Dean D Metcalfe
Journal:  Blood       Date:  2007-07-16       Impact factor: 22.113

7.  Two patients with osteoporosis: initial presentation of systemic mastocytosis.

Authors:  Marjolein L Donker; Nicolaas A Bakker; Wim J M Jaspers; Albert H Verhage
Journal:  J Bone Miner Metab       Date:  2008-02-27       Impact factor: 2.626

8.  Generation and characterization of novel canine malignant mast cell line CL1.

Authors:  Tzu-Yin Lin; Rachael Thomas; Pei-Chien Tsai; Matthew Breen; Cheryl A London
Journal:  Vet Immunol Immunopathol       Date:  2008-10-11       Impact factor: 2.046

9.  High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V.

Authors:  Robert Fritsche-Polanz; Marika Fritz; Andrea Huber; Karl Sotlar; Wolfgang R Sperr; Christine Mannhalter; Manuela Födinger; Peter Valent
Journal:  Mol Oncol       Date:  2010-04-24       Impact factor: 6.603

10.  Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816V.

Authors:  Karoline V Gleixner; Barbara Peter; Katharina Blatt; Verena Suppan; Andreas Reiter; Deepti Radia; Emir Hadzijusufovic; Peter Valent
Journal:  Haematologica       Date:  2013-03-28       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.